Clifford M Csizmar, Antoine N Saliba, Elizabeth M Swisher, Scott H Kaufmann. Cancers (Basel) 2021
Times Cited: 5
Times Cited: 5
Times Cited
Times Co-cited
Similarity
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA Mutations.
Nicholas Pulliam, Fang Fang, Ali R Ozes, Jessica Tang, Adeoluwa Adewuyi, Harold Keer, John Lyons, Stephen B Baylin, Daniela Matei, Harikrishna Nakshatri,[...]. Clin Cancer Res 2018
Nicholas Pulliam, Fang Fang, Ali R Ozes, Jessica Tang, Adeoluwa Adewuyi, Harold Keer, John Lyons, Stephen B Baylin, Daniela Matei, Harikrishna Nakshatri,[...]. Clin Cancer Res 2018
40
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
Antonella Padella, Andrea Ghelli Luserna Di Rorà, Giovanni Marconi, Martina Ghetti, Giovanni Martinelli, Giorgia Simonetti. J Hematol Oncol 2022
Antonella Padella, Andrea Ghelli Luserna Di Rorà, Giovanni Marconi, Martina Ghetti, Giovanni Martinelli, Giorgia Simonetti. J Hematol Oncol 2022
40
Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Cancer.
Nidal E Muvarak, Khadiza Chowdhury, Limin Xia, Carine Robert, Eun Yong Choi, Yi Cai, Marina Bellani, Ying Zou, Zeba N Singh, Vu H Duong,[...]. Cancer Cell 2016
Nidal E Muvarak, Khadiza Chowdhury, Limin Xia, Carine Robert, Eun Yong Choi, Yi Cai, Marina Bellani, Ying Zou, Zeba N Singh, Vu H Duong,[...]. Cancer Cell 2016
40
Therapeutic Targeting of DNA Damage Response in Cancer.
Wonyoung Choi, Eun Sook Lee. Int J Mol Sci 2022
Wonyoung Choi, Eun Sook Lee. Int J Mol Sci 2022
40
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.
Junko Murai, Shar-yin N Huang, Benu Brata Das, Amelie Renaud, Yiping Zhang, James H Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier. Cancer Res 2012
Junko Murai, Shar-yin N Huang, Benu Brata Das, Amelie Renaud, Yiping Zhang, James H Doroshow, Jiuping Ji, Shunichi Takeda, Yves Pommier. Cancer Res 2012
40
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
Helen E Bryant, Niklas Schultz, Huw D Thomas, Kayan M Parker, Dan Flower, Elena Lopez, Suzanne Kyle, Mark Meuth, Nicola J Curtin, Thomas Helleday. Nature 2005
40
PARP Inhibitor Resistance Mechanisms and Implications for Post-Progression Combination Therapies.
Elizabeth K Lee, Ursula A Matulonis. Cancers (Basel) 2020
Elizabeth K Lee, Ursula A Matulonis. Cancers (Basel) 2020
40
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.
Olga Kondrashova, Monique Topp, Ksenija Nesic, Elizabeth Lieschke, Gwo-Yaw Ho, Maria I Harrell, Giada V Zapparoli, Alison Hadley, Robert Holian, Emma Boehm,[...]. Nat Commun 2018
Olga Kondrashova, Monique Topp, Ksenija Nesic, Elizabeth Lieschke, Gwo-Yaw Ho, Maria I Harrell, Giada V Zapparoli, Alison Hadley, Robert Holian, Emma Boehm,[...]. Nat Commun 2018
40
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
40
Drug combination studies and their synergy quantification using the Chou-Talalay method.
Ting-Chao Chou. Cancer Res 2010
Ting-Chao Chou. Cancer Res 2010
40
PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage.
Benu Brata Das, Shar-yin N Huang, Junko Murai, Ishita Rehman, Jean-Christophe Amé, Souvik Sengupta, Subhendu K Das, Papiya Majumdar, Hongliang Zhang, Denis Biard,[...]. Nucleic Acids Res 2014
Benu Brata Das, Shar-yin N Huang, Junko Murai, Ishita Rehman, Jean-Christophe Amé, Souvik Sengupta, Subhendu K Das, Papiya Majumdar, Hongliang Zhang, Denis Biard,[...]. Nucleic Acids Res 2014
40
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, Tara Berman, Preeti Narayan, Daniel Suzman, Erik Bloomquist, Shenghui Tang, Yutao Gong, Rajeshwari Sridhara,[...]. Oncologist 2021
Shaily Arora, Sanjeeve Balasubramaniam, Hui Zhang, Tara Berman, Preeti Narayan, Daniel Suzman, Erik Bloomquist, Shenghui Tang, Yutao Gong, Rajeshwari Sridhara,[...]. Oncologist 2021
40
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
Robert L Coleman, Gini F Fleming, Mark F Brady, Elizabeth M Swisher, Karina D Steffensen, Michael Friedlander, Aikou Okamoto, Kathleen N Moore, Noa Efrat Ben-Baruch, Theresa L Werner,[...]. N Engl J Med 2019
Robert L Coleman, Gini F Fleming, Mark F Brady, Elizabeth M Swisher, Karina D Steffensen, Michael Friedlander, Aikou Okamoto, Kathleen N Moore, Noa Efrat Ben-Baruch, Theresa L Werner,[...]. N Engl J Med 2019
40
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
40
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää,[...]. N Engl J Med 2019
Isabelle Ray-Coquard, Patricia Pautier, Sandro Pignata, David Pérol, Antonio González-Martín, Regina Berger, Keiichi Fujiwara, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää,[...]. N Engl J Med 2019
40
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René DePont Christensen, Whitney Graybill, Mansoor R Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer,[...]. N Engl J Med 2019
Antonio González-Martín, Bhavana Pothuri, Ignace Vergote, René DePont Christensen, Whitney Graybill, Mansoor R Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer,[...]. N Engl J Med 2019
40
5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells.
Christoph Oing, Izudin Verem, Wael Y Mansour, Carsten Bokemeyer, Sergey Dyshlovoy, Friedemann Honecker. Int J Mol Sci 2018
Christoph Oing, Izudin Verem, Wael Y Mansour, Carsten Bokemeyer, Sergey Dyshlovoy, Friedemann Honecker. Int J Mol Sci 2018
20
Eukaryotic cytosine methyltransferases.
Mary Grace Goll, Timothy H Bestor. Annu Rev Biochem 2005
Mary Grace Goll, Timothy H Bestor. Annu Rev Biochem 2005
20
5-Azacitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis.
Sha Jin, Dan Cojocari, Julie J Purkal, Relja Popovic, Nari N Talaty, Yu Xiao, Larry R Solomon, Erwin R Boghaert, Joel D Leverson, Darren C Phillips. Clin Cancer Res 2020
Sha Jin, Dan Cojocari, Julie J Purkal, Relja Popovic, Nari N Talaty, Yu Xiao, Larry R Solomon, Erwin R Boghaert, Joel D Leverson, Darren C Phillips. Clin Cancer Res 2020
20
The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.
Tatiana Kamaletdinova, Zahra Fanaei-Kahrani, Zhao-Qi Wang. Cells 2019
Tatiana Kamaletdinova, Zahra Fanaei-Kahrani, Zhao-Qi Wang. Cells 2019
20
Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.
Louise J Barber, Shahneen Sandhu, Lina Chen, James Campbell, Iwanka Kozarewa, Kerry Fenwick, Ioannis Assiotis, Daniel Nava Rodrigues, Jorge S Reis Filho, Victor Moreno,[...]. J Pathol 2013
Louise J Barber, Shahneen Sandhu, Lina Chen, James Campbell, Iwanka Kozarewa, Kerry Fenwick, Ioannis Assiotis, Daniel Nava Rodrigues, Jorge S Reis Filho, Victor Moreno,[...]. J Pathol 2013
20
DNA Methylation Reprogramming during Mammalian Development.
Yang Zeng, Taiping Chen. Genes (Basel) 2019
Yang Zeng, Taiping Chen. Genes (Basel) 2019
20
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Verona Buocikova, Eleonora Marta Longhin, Eleftherios Pilalis, Chara Mastrokalou, Svetlana Miklikova, Marina Cihova, Alexandra Poturnayova, Katarina Mackova, Andrea Babelova, Lenka Trnkova,[...]. Biomed Pharmacother 2022
Verona Buocikova, Eleonora Marta Longhin, Eleftherios Pilalis, Chara Mastrokalou, Svetlana Miklikova, Marina Cihova, Alexandra Poturnayova, Katarina Mackova, Andrea Babelova, Lenka Trnkova,[...]. Biomed Pharmacother 2022
20
The transcriptional landscape and mutational profile of lung adenocarcinoma.
Jeong-Sun Seo, Young Seok Ju, Won-Chul Lee, Jong-Yeon Shin, June Koo Lee, Thomas Bleazard, Junho Lee, Yoo Jin Jung, Jung-Oh Kim, Jung-Young Shin,[...]. Genome Res 2012
Jeong-Sun Seo, Young Seok Ju, Won-Chul Lee, Jong-Yeon Shin, June Koo Lee, Thomas Bleazard, Junho Lee, Yoo Jin Jung, Jung-Oh Kim, Jung-Young Shin,[...]. Genome Res 2012
20
Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements.
Gangning Liang, Matilda F Chan, Yoshitaka Tomigahara, Yvonne C Tsai, Felicidad A Gonzales, En Li, Peter W Laird, Peter A Jones. Mol Cell Biol 2002
Gangning Liang, Matilda F Chan, Yoshitaka Tomigahara, Yvonne C Tsai, Felicidad A Gonzales, En Li, Peter W Laird, Peter A Jones. Mol Cell Biol 2002
20
Kinase-mediated changes in nucleosome conformation trigger chromatin decondensation via poly(ADP-ribosyl)ation.
Colin J Thomas, Elena Kotova, Mark Andrake, Jared Adolf-Bryfogle, Robert Glaser, Catherine Regnard, Alexei V Tulin. Mol Cell 2014
Colin J Thomas, Elena Kotova, Mark Andrake, Jared Adolf-Bryfogle, Robert Glaser, Catherine Regnard, Alexei V Tulin. Mol Cell 2014
20
Research Advances in the Role of the Poly ADP Ribose Polymerase Family in Cancer.
Huanhuan Sha, Yujie Gan, Renrui Zou, Jianzhong Wu, Jifeng Feng. Front Oncol 2021
Huanhuan Sha, Yujie Gan, Renrui Zou, Jianzhong Wu, Jifeng Feng. Front Oncol 2021
50
Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci.
Alexei Tulin, Allan Spradling. Science 2003
Alexei Tulin, Allan Spradling. Science 2003
20
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design.
Neeraj Agarwal, Arun Azad, Neal D Shore, Joan Carles, Andre P Fay, Curtis Dunshee, Lawrence Ivan Karsh, Maria Luisa Paccagnella, Nicola Di Santo, Mohamed Elmeliegy,[...]. Future Oncol 2022
Neeraj Agarwal, Arun Azad, Neal D Shore, Joan Carles, Andre P Fay, Curtis Dunshee, Lawrence Ivan Karsh, Maria Luisa Paccagnella, Nicola Di Santo, Mohamed Elmeliegy,[...]. Future Oncol 2022
25
DNA methyltransferase expression and DNA methylation of CPG islands and peri-centromeric satellite regions in human colorectal and stomach cancers.
Y Kanai, S Ushijima, Y Kondo, Y Nakanishi, S Hirohashi. Int J Cancer 2001
Y Kanai, S Ushijima, Y Kondo, Y Nakanishi, S Hirohashi. Int J Cancer 2001
20
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.
Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Manel Esteller, Se-Hoon Lee, Jung Kyoon Choi. Nat Commun 2019
Hyunchul Jung, Hong Sook Kim, Jeong Yeon Kim, Jong-Mu Sun, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Manel Esteller, Se-Hoon Lee, Jung Kyoon Choi. Nat Commun 2019
20
Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer.
Nair Lopes, Mariana Brütt Pacheco, Diana Soares-Fernandes, Margareta P Correia, Vânia Camilo, Rui Henrique, Carmen Jerónimo. Biomedicines 2021
Nair Lopes, Mariana Brütt Pacheco, Diana Soares-Fernandes, Margareta P Correia, Vânia Camilo, Rui Henrique, Carmen Jerónimo. Biomedicines 2021
100
TET family dioxygenases and DNA demethylation in stem cells and cancers.
Jungeun An, Anjana Rao, Myunggon Ko. Exp Mol Med 2017
Jungeun An, Anjana Rao, Myunggon Ko. Exp Mol Med 2017
20
PARP1 orchestrates epigenetic events setting up chromatin domains.
Fabio Ciccarone, Michele Zampieri, Paola Caiafa. Semin Cell Dev Biol 2017
Fabio Ciccarone, Michele Zampieri, Paola Caiafa. Semin Cell Dev Biol 2017
20
Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs.
Francesco Neri, Anna Krepelova, Danny Incarnato, Mara Maldotti, Caterina Parlato, Federico Galvagni, Filomena Matarese, Hendrik G Stunnenberg, Salvatore Oliviero. Cell 2013
Francesco Neri, Anna Krepelova, Danny Incarnato, Mara Maldotti, Caterina Parlato, Federico Galvagni, Filomena Matarese, Hendrik G Stunnenberg, Salvatore Oliviero. Cell 2013
20
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
J G Herman, F Latif, Y Weng, M I Lerman, B Zbar, S Liu, D Samid, D S Duan, J R Gnarra, W M Linehan. Proc Natl Acad Sci U S A 1994
J G Herman, F Latif, Y Weng, M I Lerman, B Zbar, S Liu, D Samid, D S Duan, J R Gnarra, W M Linehan. Proc Natl Acad Sci U S A 1994
20
Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers.
Peter Makhov, Robert G Uzzo, Alexei V Tulin, Vladimir M Kolenko. Urol Oncol 2021
Peter Makhov, Robert G Uzzo, Alexei V Tulin, Vladimir M Kolenko. Urol Oncol 2021
20
Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.
Jun Gao, Lihua Wang, Jinkang Xu, Jianming Zheng, Xiaohua Man, Hongyu Wu, Jin Jin, Kaixuan Wang, Huasheng Xiao, Shude Li,[...]. J Exp Clin Cancer Res 2013
Jun Gao, Lihua Wang, Jinkang Xu, Jianming Zheng, Xiaohua Man, Hongyu Wu, Jin Jin, Kaixuan Wang, Huasheng Xiao, Shude Li,[...]. J Exp Clin Cancer Res 2013
20
The NF-kappa B and I kappa B proteins: new discoveries and insights.
A S Baldwin. Annu Rev Immunol 1996
A S Baldwin. Annu Rev Immunol 1996
20
Poly(ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions.
M Malanga, J M Pleschke, H E Kleczkowska, F R Althaus. J Biol Chem 1998
M Malanga, J M Pleschke, H E Kleczkowska, F R Althaus. J Biol Chem 1998
20
Metformin Increases the Chemosensitivity of Pancreatic Cancer Cells to Gemcitabine by Reversing EMT Through Regulation DNA Methylation of miR-663.
Yuqing Gu, Bin Zhang, Guangliang Gu, Xiaojun Yang, Zhuyin Qian. Onco Targets Ther 2020
Yuqing Gu, Bin Zhang, Guangliang Gu, Xiaojun Yang, Zhuyin Qian. Onco Targets Ther 2020
20
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes.
W M Rideout, G A Coetzee, A F Olumi, P A Jones. Science 1990
W M Rideout, G A Coetzee, A F Olumi, P A Jones. Science 1990
20
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair.
Yimei Feng, Xiaoping Li, Kaniel Cassady, Zhongmin Zou, Xi Zhang. Front Oncol 2019
Yimei Feng, Xiaoping Li, Kaniel Cassady, Zhongmin Zou, Xi Zhang. Front Oncol 2019
20
Delivery of 5-azacytidine to human cancer cells by elaidic acid esterification increases therapeutic drug efficacy.
Bodo Brueckner, Maria Rius, Maria Rivera Markelova, Iduna Fichtner, Petter-Arnt Hals, Marit Liland Sandvold, Frank Lyko. Mol Cancer Ther 2010
Bodo Brueckner, Maria Rius, Maria Rivera Markelova, Iduna Fichtner, Petter-Arnt Hals, Marit Liland Sandvold, Frank Lyko. Mol Cancer Ther 2010
20
The unmethylated state of CpG islands in mouse fibroblasts depends on the poly(ADP-ribosyl)ation process.
G Zardo, P Caiafa. J Biol Chem 1998
G Zardo, P Caiafa. J Biol Chem 1998
20
Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors.
Mei Han, Lina Jia, Wencai Lv, Lihui Wang, Wei Cui. Front Oncol 2019
Mei Han, Lina Jia, Wencai Lv, Lihui Wang, Wei Cui. Front Oncol 2019
20
Poly(ADP)-Ribosylation Inhibition: A Promising Approach for Clear Cell Renal Cell Carcinoma Therapy.
Yaroslava Karpova, Danping Guo, Peter Makhov, Adam M Haines, Dmitriy A Markov, Vladimir Kolenko, Alexei V Tulin. Cancers (Basel) 2021
Yaroslava Karpova, Danping Guo, Peter Makhov, Adam M Haines, Dmitriy A Markov, Vladimir Kolenko, Alexei V Tulin. Cancers (Basel) 2021
20
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing.
Anna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, Julian Mauch, Sabine Kelkenberg-Schade, Berit Haldemann, Tamara Fries, Jan Krönke, Michael W M Kühn, Peter Paschka,[...]. Blood 2012
Anna Dolnik, Julia C Engelmann, Maren Scharfenberger-Schmeer, Julian Mauch, Sabine Kelkenberg-Schade, Berit Haldemann, Tamara Fries, Jan Krönke, Michael W M Kühn, Peter Paschka,[...]. Blood 2012
20
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.